KRONOS BIO INC's ticker is KRON and the CUSIP is 50107A104. A total of 65 filers reported holding KRONOS BIO INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,100 | -40.5% | 4,692 | -21.3% | 0.00% | – |
| Q2 2023 | $10,260 | -15.9% | 5,965 | -28.6% | 0.00% | – |
| Q1 2023 | $12,196 | -98.8% | 8,354 | -98.7% | 0.00% | – |
| Q4 2022 | $1,007,222 | -80.0% | 621,742 | -58.7% | 0.00% | -100.0% |
| Q3 2022 | $5,039,000 | -7.6% | 1,504,234 | +0.4% | 0.00% | 0.0% |
| Q2 2022 | $5,456,000 | -62.0% | 1,498,908 | -24.5% | 0.00% | 0.0% |
| Q1 2022 | $14,363,000 | -40.0% | 1,986,527 | +12.8% | 0.00% | -50.0% |
| Q4 2021 | $23,943,000 | -29.8% | 1,761,794 | +8.3% | 0.00% | -33.3% |
| Q3 2021 | $34,108,000 | -20.5% | 1,627,288 | -9.1% | 0.00% | 0.0% |
| Q2 2021 | $42,894,000 | -25.1% | 1,790,995 | -9.1% | 0.00% | -40.0% |
| Q1 2021 | $57,290,000 | -21.5% | 1,969,703 | -23.3% | 0.01% | -16.7% |
| Q4 2020 | $73,004,000 | – | 2,567,902 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,765,314 | $9,264,000 | 8.31% |
| Omega Fund Management, LLC | 3,818,283 | $12,791,000 | 4.68% |
| Privium Fund Management (UK) Ltd | 645,331 | $2,162,000 | 2.76% |
| Wildcat Capital Management, LLC | 1,438,232 | $4,818,000 | 1.85% |
| Nextech Invest Ltd. | 1,451,537 | $4,863,000 | 1.57% |
| Alphabet Inc. | 1,438,232 | $4,818,000 | 0.25% |
| Artal Group S.A. | 1,542,954 | $5,169,000 | 0.22% |
| Perceptive Advisors | 2,156,151 | $7,223,000 | 0.21% |
| Oasis Management Co Ltd. | 196,078 | $657,000 | 0.11% |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 527,500 | $1,767,000 | 0.10% |